This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Search for:
Search for:
News
Clinical
Allergy
Cardiovascular
Emergency and critical care
Oncology/Haematology
Gastroenterology
Radiology and Imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Reports
Country profiles
Clinical Excellence
Cardiology
Respiratory
Archive Issues
2021
2020
2019
2018
2017
2016
Sponsored
Newsletter
Hospital Pharmacy Europe
Oncology
Rucaparib offers survival advantage over usual care in metastatic prostate cancer
Read more
Poor cardiovascular risk control identified in half of men with prostate cancer
Read more
Pembrolizumab shows benefit in high-risk BCG non-responsive bladder cancer
Read more
Darolutamide improves overall survival in metastatic hormone sensitive prostate cancer
Read more
Neoadjuvant nivolumab provides significant 5-year overall survival in lung cancer
Read more
RCT shows Ide-cel effective in refractory or relapsed multiple myeloma
Read more
Novel prostate cancer screening test highly accurate
Read more
Single low-dose CT scan helps predict future lung cancer risk
Read more
Yescarta approved by NICE for relapsed/remitted lymphomas
Read more
T cell biomarker predicts CAR T cell therapy response in relapsed lymphoma
Read more
CTX-009 shows promise in biliary tract cancer
Read more
Glyphosate use associated with elevated biomarkers of oxidative DNA damage
Read more
Infusion of novel agent reduces oral mucositis following chemoradiotherapy
Read more
Contrast-enhanced CT enables prediction of treatment response in liver cancer
Read more
MRI guided stereotactic radiotherapy superior to CT in prostate cancer
Read more
Page 2 of 34
«
1
2
3
4
5
...
10
20
30
...
»
Last »
Popular articles
Government commits to easing pressure on NHS through commercial clinical trial investment
26 May, 2023
Biobank pilot to be launched by MHRA to better understand genetics and medicines safety
26 May, 2023
Understanding the intricacies of tube feeding with Stephen Taylor
25 May, 2023